Safety Study of LiRIS in Interstitial Cystitis (IC) Patients

NCT01150565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Cystitis

Interventions

DRUG: LiRIS low dose and LiRIS high dose

Sponsor

Allergan

Collaborators

[object Object]